Meeting Highlights: Genome Informatics
نویسندگان
چکیده
منابع مشابه
Meeting Highlights: Genome Informatics
We bring you the highlights of the second Joint Cold Spring Harbor Laboratory and Wellcome Trust 'Genome Informatics' Conference, organized by Ewan Birney, Suzanna Lewis and Lincoln Stein. There were sessions on in silico data discovery, comparative genomics, annotation pipelines, functional genomics and integrative biology. The conference included a keynote address by Sydney Brenner, who was a...
متن کاملMeeting Highlights: Joint Cold Spring Harbor Laboratory and Wellcome Trust Conference – Genome Informatics
Ewan Birney (EBI, UK) opened the meeting with a presentation on the Ensembl gene building system (http://www.ensembl.org). The first part of the process is Exonerate (Guy Slater), this is the ‘basic guts’ of BLAST, allows multiplexing and makes a lazy evaluation of the path between HSPs, to rapidly build gapped alignments. This was designed for ESTs, but is now being applied to mouse whole geno...
متن کاملMeeting Highlights: Genome Sequencing and Biology 2001
We bring you a report from the CSHL Genome Sequencing and Biology Meeting, which has a long and prestigious history. This year there were sessions on large-scale sequencing and analysis, polymorphisms (covering discovery and technologies and mapping and analysis), comparative genomics of mammalian and model organism genomes, functional genomics and bioinformatics.
متن کاملMeeting Highlights: 15th International Mouse Genome Conference
After the official opening of the meeting by Ian Jackson (MRC Human Genetics Unit, UK), John McPherson (Washington University, USA) gave his plenary lecture Mapping and sequencing the mouse genome. He started with a report on the status of 'the other genome' (human), stating that they now have y2.9 Gb of sequence, 1.75 Gb of which is 'finished' and 99% of which is aligned to the chromosomes. Ch...
متن کاملMeeting Report Cancer Immunotherapy Highlights from the 2014 ASCO Meeting
The promise of cancer immunotherapy was validated officially in March 2011 when the FDA approved Yervoy (ipilimumab; Bristol-Myers Squibb) for the treatment of unresectable ormetastatic melanoma. The approval was based on results of a randomized, double-blind clinical trial establishing that ipilimumab (a humanized antiCTLA-4 monoclonal antibody) treatment extended the overall survival of patie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Comparative and Functional Genomics
سال: 2003
ISSN: 1531-6912,1532-6268
DOI: 10.1002/cfg.300